Skip to Content

Current Oncology, Volume 28, Issue 3

2021 June - 65 articles

Cover Story: It is projected that one in two Canadians will be diagnosed with cancer in their lifetime. Fortunately, as a result of the progress made in diagnostic and treatment options, the incidence of cancer mortality is decreasing, and more individuals are surviving cancer than ever before. However, the impact that cancer has on one’s life does not end with treatment; cancer survivors indicate that the first year following the end of treatment is difficult, as they struggle to adjust to their new normal and experience both physical and psychosocial challenges throughout the survivorship phase. This scoping review provides a description of the current supportive care interventions and transitional care models studied in the context of Canadian cancer survivors and determines how they align with the current Canadian supportive care guidelines. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (65)

  • Article
  • Open Access
4 Citations
3,520 Views
12 Pages

20 June 2021

Chemoembolization with irinotecan-loaded microspheres has proven effective in the treatment of unresectable liver metastases in the course of colorectal cancer (CRC). Most researchers recommend slowly administering the embolizate at the level of the...

  • Article
  • Open Access
6 Citations
3,526 Views
15 Pages

Transcriptomic Landscape of Lower Grade Glioma Based on Age-Related Non-Silent Somatic Mutations

  • YoungJoon Park,
  • JeongMan Park,
  • Ju Won Ahn,
  • Jeong Min Sim and ,
  • Su Jung Kang,
  • Suwan Kim,
  • So Jung Hwang,
  • Song-Hee Han,
  • Kyoung Su Sung and
  • Jaejoon Lim
  • + 5 authors+ 0 author

19 June 2021

Glioma accounts for 80% of all malignant brain tumours and is the most common adult primary brain tumour. Age is an important factor affecting the development of cancer, as somatic mutations accumulate with age. Here, we aimed to analyse the signific...

(This article belongs to the Section Neuro-Oncology)
  • Article
  • Open Access
5 Citations
5,443 Views
10 Pages

18 June 2021

In the UK, Trifluridine-tipiracil (Lonsurf) is used to treat metastatic colorectal cancer in the third-line setting, after prior exposure to fluoropyrimidine-based regimes. Current data on the real-world use of Lonsurf lack long-term follow-up data....

  • Article
  • Open Access
13 Citations
3,777 Views
11 Pages

18 June 2021

In this analysis, we describe population-based outcomes for first-line treatment with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) combined with an aromatase inhibitor (AI). All patients who were prescribed CDK4/6i + AI from January 2016 through...

  • Article
  • Open Access
57 Citations
7,615 Views
12 Pages

17 June 2021

Patients awaiting cancer treatment were classified as “vulnerable” and advised to shield to protect themselves from exposure to coronavirus during the pandemic. These measures can negatively impact patients. We sought to establish the feasibility and...

  • Article
  • Open Access
2 Citations
3,475 Views
9 Pages

Colorectal Cancer Surgery Quality in Manitoba: A Population-Based Descriptive Analysis

  • Iresha Ratnayake,
  • Jason Park,
  • Natalie Biswanger,
  • Allison Feely and ,
  • Grace Musto and
  • Kathleen Decker
  • + 1 author+ 0 author

16 June 2021

Unwarranted clinical variation in healthcare impacts access, productivity, performance, and outcomes. A strategy proposed for reducing unwarranted clinical variation is to ensure that population-based data describing the current state of health care...

(This article belongs to the Section Surgical Oncology)
  • Conference Report
  • Open Access
2 Citations
5,554 Views
28 Pages

Abstracts of the 2021 Canadian Association of Medical Oncologists Annual Meeting

  • Jonathan Loree,
  • Erin Powell,
  • Sharlene Gill,
  • Stephen Welch and ,
  • Bruce Colwell and
  • Desiree Hao
  • + 1 author+ 0 author

15 June 2021

On behalf of the Canadian Association of Medical Oncologists, we are pleased to present the Abstracts of the 2021 Annual Meeting. The National CAMO Residents Research Day was held virtually on 1 April 2021 and the CAMO Virtual Annual Scientific Meeti...

  • Article
  • Open Access
7 Citations
4,448 Views
12 Pages

“What We Want Is More Access…”: Experiences of Supportive Cancer Care and Strategies for Advancement in a Canadian Provincial Cancer Care Organization

  • Jonathan Avery,
  • Hannah K. Schulte,
  • Kristin L. Campbell,
  • Alan Bates and ,
  • Lisa McCune and
  • Amanda Fuchsia Howard
  • + 1 author+ 0 author

15 June 2021

Objectives: Despite calls for better supportive care, patients and families still commonly bear significant responsibility for managing the physical and mental health and social challenges of being diagnosed with and treated for cancer. As such, ther...

  • Article
  • Open Access
9 Citations
4,136 Views
10 Pages

Comparison of Patient-Reported Experience of Patients Receiving Radiotherapy Measured by Two Validated Surveys

  • Abdulla Al-Rashdan,
  • Linda Watson,
  • Demetra Yannitsos,
  • Siwei Qi and ,
  • Petra Grendarova and
  • Lisa Barbera
  • + 1 author+ 0 author

12 June 2021

Patient-reported experience is associated with improved patient safety and clinical outcomes. Quality improvement programs rely on validated patient-reported experience measures (PREMs) to design projects. This descriptive study compares the experien...

  • Article
  • Open Access
10 Citations
4,249 Views
9 Pages

12 June 2021

Background: In 2012, the American Society for Clinical Oncology (ASCO) identified five key opportunities in oncology to improve patient care, recommending against imaging tests for the staging of patients with early breast cancer (EBC) at low risk fo...

(This article belongs to the Section Medical Oncology)
  • Article
  • Open Access
16 Citations
7,037 Views
23 Pages

Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells

  • Ritu Shrestha,
  • Kim R. Bridle,
  • Lu Cao,
  • Darrell H. G. Crawford and
  • Aparna Jayachandran

11 June 2021

Sorafenib, an oral multi-tyrosine kinase inhibitor, has been the first-line therapy for the treatment of patients with advanced HCC, providing a survival benefit of only three months in approximately 30% of patients. Cancer stem cells (CSCs) are a ra...

  • Communication
  • Open Access
23 Citations
4,808 Views
7 Pages

Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events

  • Daniel V. Araujo,
  • Thiago Pimentel Muniz,
  • Anjie Yang,
  • Sareh Keshavarzi and ,
  • Hadas Sorotsky,
  • Marcus O. Butler,
  • Samuel Saibil,
  • Anna Spreafico and
  • David Hogg
  • + 4 authors+ 0 author

11 June 2021

Background and aims: Current guidelines state that infliximab is contraindicated for the treatment of immune checkpoint inhibitor-related hepatitis (ir-hepatitis) due to the risk of inducing further liver damage. As this recommendation is largely bas...

(This article belongs to the Section Medical Oncology)
  • Case Report
  • Open Access
3 Citations
3,676 Views
4 Pages

10 June 2021

A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her response to this treatment.

  • Article
  • Open Access
21 Citations
9,080 Views
11 Pages

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making

  • Philipp Mandel,
  • Mike Wenzel,
  • Benedikt Hoeh,
  • Maria N. Welte and ,
  • Felix Preisser,
  • Tahir Inam,
  • Clarissa Wittler,
  • Clara Humke,
  • Jens Köllermann and
  • Andreas Becker
  • + 12 authors+ 7 authors

9 June 2021

Background: To test the value of immunohistochemistry (IHC) staining in prostate biopsies for changes in biopsy results and its impact on treatment decision-making. Methods: Between January 2017–June 2020, all patients undergoing prostate biopsies we...

(This article belongs to the Section Genitourinary Oncology)
  • Review
  • Open Access
10 Citations
6,234 Views
12 Pages

9 June 2021

(1) Background: One in two Canadians will be diagnosed with cancer in their lifetime, but as a result of the progress in diagnosis and treatment, more individuals are surviving cancer than ever before. However, the impact of cancer does not end with...

(This article belongs to the Section Palliative and Supportive Care)
  • Case Report
  • Open Access
5 Citations
7,392 Views
8 Pages

Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix

  • Harry J. Gould,
  • Paige R. Miller,
  • Samantha Edenfield,
  • Kelly Jean Sherman and ,
  • Chad K. Brady and
  • Dennis Paul
  • + 1 author+ 0 author

8 June 2021

Upregulation of voltage-gated sodium channels (VGSCs) and Na+/K+-ATPase (sodium pumps) is common across most malignant carcinomas. Targeted osmotic lysis (TOL) is a developing technology in which the concomitant stimulation of VGSCs and pharmacologic...

  • Communication
  • Open Access
12 Citations
5,592 Views
8 Pages

5 June 2021

Coordinating breast cancer treatment is a complex task that can overwhelm patients and their support networks. Though the Cancer Patient Navigator (CPN) program in Nova Scotia (NS) provides professional assistance to patients, certain groups of patie...

(This article belongs to the Section Psychosocial Oncology)
  • Article
  • Open Access
8 Citations
4,927 Views
10 Pages

The Screening and COnsensus Based on Practices and Evidence (SCOPE) Program–Results of a Survey on Daily Practice Patterns for Patients with mCRC

  • Gerald Prager,
  • Claus-Henning Köhne,
  • Juan Manuel O’Connor,
  • Fernando Rivera and ,
  • Daniele Santini,
  • Harpreet Wasan and
  • Jean Marc Phelip
  • + 2 authors+ 0 author

4 June 2021

The SCOPE project aimed to better understand practice patterns, identify drivers for treatment goals, and determine third- and fourth-line treatment choices for patients with metastatic colorectal cancer (mCRC). The survey was developed by an expert...

(This article belongs to the Section Gastrointestinal Oncology)
  • Feature Paper
  • Article
  • Open Access
12 Citations
4,781 Views
8 Pages

Quality of Colon Cancer Care in Patients Undergoing Emergency Surgery

  • Keegan Guidolin,
  • Rebecca Withers,
  • Farhana Shariff,
  • Shady Ashamalla and
  • Ashlie Nadler

3 June 2021

Thirty percent of colon cancer diagnoses occur following emergency presentations, often with bowel obstruction or perforation requiring urgent surgery. We sought to compare cancer care quality between patients receiving emergency versus elective surg...

(This article belongs to the Section Gastrointestinal Oncology)
  • Review
  • Open Access
7 Citations
5,005 Views
10 Pages

Possible Therapeutic Potential of Disulfiram for Multiple Myeloma

  • Denisa Weiser Drozdkova and
  • Katerina Smesny Trtkova

3 June 2021

Multiple myeloma (MM) is a malignant disease of the plasma cells representing approximately 10% of all hemato-oncological diseases. Detection of the disease is most probable at around 65 years of age, and the average survival of patients is estimated...

(This article belongs to the Section Medical Oncology)
  • Review
  • Open Access
6 Citations
5,703 Views
14 Pages

Interventions and Outcomes for Neoadjuvant Treatment of T4 Colon Cancer: A Scoping Review

  • Flora Jung,
  • Keegan Guidolin,
  • Michael Ho-Yan Lee,
  • Kimberley Lam-Tin-Cheung and ,
  • Grace Zhao,
  • Sachin Doshi,
  • Tyler Chesney,
  • Marina Englesakis,
  • Jelena Lukovic and
  • Sami A. Chadi
  • + 7 authors+ 2 authors

29 May 2021

While adjuvant treatment of colon cancers that penetrate the serosa (T4) have been well-established, neoadjuvant strategies have yet to be formally evaluated. Our objective was to perform a scoping review of eligibility criteria, treatment regimens,...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
12 Citations
7,734 Views
13 Pages

Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada

  • Leila Cattelan,
  • Feras M. Ghazawi,
  • Michelle Le,
  • François Lagacé and ,
  • Elham Rahme,
  • Andrei Zubarev,
  • Denis Sasseville,
  • Ivan V. Litvinov,
  • Kevin A. Waschke and
  • Elena Netchiporouk
  • + 5 authors+ 0 author

28 May 2021

Gastric cancer is the 5th most common malignancy worldwide, representing ~5–10% of all new cancer cases. Although its incidence is declining, it is estimated that 1 in 98 Canadians will develop gastric cancer in their lifetime. The epidemiology and d...

(This article belongs to the Section Gastrointestinal Oncology)
  • Conference Report
  • Open Access
3 Citations
3,313 Views
12 Pages

27 May 2021

Introduction: There are a lack of established guidelines for the surveillance of high-risk cutaneous melanoma patients following initial therapy. We describe a novel approach to the development of a national expert recommendation statement on high-ri...

  • Conference Report
  • Open Access
5 Citations
5,449 Views
19 Pages

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019

  • Joanna Gotfrit,
  • Rachel Goodwin,
  • Timothy Asmis,
  • Angela J. Hyde and ,
  • Thierry Alcindor,
  • Francine Aubin,
  • Scott Berry,
  • Dominick Bossé,
  • Colin Brown and
  • Michael Vickers
  • + 35 authors+ 30 authors

26 May 2021

The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19–21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management of...

(This article belongs to the Section Gastrointestinal Oncology)
  • Commentary
  • Open Access
4 Citations
5,143 Views
7 Pages

26 May 2021

The COVID-19 situation is a worldwide health emergency with strong implications in clinical oncology. In this viewpoint, we address two crucial dilemmas from the ethical dimension: (1) Is it ethical to postpone or suspend cancer treatments which offe...

(This article belongs to the Section Medical Oncology)
  • Article
  • Open Access
7 Citations
4,912 Views
15 Pages

Results from a Theory-Guided Survey to Support Breast Cancer Trial Participation: Barriers, Enablers, and What to Do about them

  • Jamie C. Brehaut,
  • Kelly Carroll,
  • Jenn Gordon,
  • Justin Presseau and ,
  • Dawn P. Richards,
  • Dean A. Fergusson,
  • Ian D. Graham and
  • Susan Marlin
  • + 3 authors+ 0 author

26 May 2021

Background: Ensuring adequate, informed, and timely participation in clinical trials is a multifactorial problem. We have previously developed a systematic, tailorable survey development approach that is informed by theory, can identify barriers and...

  • Article
  • Open Access
5 Citations
5,316 Views
11 Pages

Testing Mayo Clinic’s New 20/20/20 Risk Model in Another Cohort of Smoldering Myeloma Patients: A Retrospective Study

  • Camille Tessier,
  • Thomas Allard,
  • Jean-Samuel Boudreault,
  • Rayan Kaedbey and ,
  • Vincent Éthier,
  • Fléchère Fortin and
  • Michel Pavic
  • + 2 authors+ 0 author

26 May 2021

Background—smoldering multiple myeloma (SMM) risk of progression to multiple myeloma (MM) is highly heterogeneous and several models have been suggested to predict this risk. Lakshman et al. recently proposed a model based on three biomarkers: bone m...

(This article belongs to the Section Hematology)
  • Case Report
  • Open Access
2 Citations
4,855 Views
8 Pages

An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report)

  • Martina Panebianco,
  • Beatrice Taurelli Salimbeni,
  • Michela Roberto and
  • Paolo Marchetti

25 May 2021

Background. Personalized therapy is becoming increasingly popular in oncological scenarios, not only based on molecular pharmacological targets, but also preventing any drug–drug–gene interaction (DDGI), which could lead to severe toxicities. Single...

  • Case Report
  • Open Access
12 Citations
3,823 Views
5 Pages

A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer

  • Marta Piras,
  • Martina Panebianco,
  • Matteo Garibaldi,
  • Michela Roberto and ,
  • Gioia Merlonghi,
  • Patrizia Pellegrini and
  • Paolo Marchetti
  • + 2 authors+ 0 author

24 May 2021

Introduction. Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM) mainly characterized by subacute muscle weakness and skin rash sometimes associated with malignancy. Case Presentation. A 61-year-old female was admitted to our hospital...

  • Article
  • Open Access
14 Citations
5,394 Views
18 Pages

Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment

  • Abdulaziz Alhussan,
  • Kyle Bromma,
  • Ece Pinar Demirci Bozdoğan,
  • Andrew Metcalfe and ,
  • Joanna Karasinska,
  • Wayne Beckham,
  • Abraham S. Alexander,
  • Daniel J. Renouf,
  • David F. Schaeffer and
  • Devika B. Chithrani
  • + 5 authors+ 0 author

24 May 2021

Pancreatic cancer is one of the deadliest types of cancer, with a five-year survival rate of only 10%. Nanotechnology offers a novel perspective to treat such deadly cancers through their incorporation into radiotherapy and chemotherapy. However, the...

(This article belongs to the Section Medical Oncology)
  • Article
  • Open Access
28 Citations
4,606 Views
11 Pages

Lung Cancer Inequalities in Stage of Diagnosis in Ontario, Canada

  • Aisha K. Lofters,
  • Evgenia Gatov,
  • Hong Lu,
  • Nancy N. Baxter and ,
  • Sara J. T. Guilcher,
  • Alexander Kopp,
  • Mandana Vahabi and
  • Geetanjali D. Datta
  • + 3 authors+ 0 author

23 May 2021

Lung cancer is the most common cancer and cause of cancer death in Canada, with approximately 50% of cases diagnosed at stage IV. Sociodemographic inequalities in lung cancer diagnosis have been documented, but it is not known if inequalities exist w...

  • Case Report
  • Open Access
2 Citations
3,245 Views
8 Pages

Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report

  • Keiji Sugiyama,
  • Ai Izumika,
  • Akari Iwakoshi,
  • Riko Nishibori and ,
  • Mariko Sato,
  • Kazuhiro Shiraishi,
  • Hiroyoshi Hattori,
  • Rieko Nishimura and
  • Chiyoe Kitagawa
  • + 4 authors+ 0 author

21 May 2021

Gene alteration in anaplastic lymphoma kinase (ALK) is rare, and the efficacy of ALK inhibitors in the treatment of carcinoma of unknown primary (CUP) with ALK alteration remains unclear. The patient was a 56-year-old woman who presented with cervica...

  • Case Report
  • Open Access
10 Citations
3,480 Views
6 Pages

20 May 2021

The role and timing of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma receiving immunotherapy-based regimens is unclear. However, the ability to achieve a complete response for metastatic renal cell carcinoma likely requir...

  • Article
  • Open Access
10 Citations
3,973 Views
11 Pages

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer

  • Ye-Rin Kim,
  • Ki-Uk Kim,
  • Jung-Hee Lee,
  • Deok-Won Kim and ,
  • Jae-Heun Chung,
  • Yeong-Dae Kim,
  • Dong-Hoon Shin,
  • Min-Ki Lee,
  • Yong-Il Shin and
  • Sang-Yull Lee
  • + 5 authors+ 0 author

20 May 2021

To identify cancer/testis (CT) antigens and immunogenic proteins, immunoscreening of testicular and small-cell lung cancer cell line NCI-H889 cDNA libraries was performed using serum obtained from a small-cell lung cancer (SCLC) patient. We obtained...

  • Review
  • Open Access
206 Citations
23,870 Views
12 Pages

Synovial Sarcoma: A Clinical Review

  • Aaron M. Gazendam,
  • Snezana Popovic,
  • Sohaib Munir,
  • Naveen Parasu and ,
  • David Wilson and
  • Michelle Ghert
  • + 1 author+ 0 author

19 May 2021

Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5–10% of all STS. Synovial sarcoma differs from other STS by the relatively young age at diagnosis and clinical presentation. Synovial sarcomas have unique...

(This article belongs to the Section Surgical Oncology)
  • Article
  • Open Access
5 Citations
3,817 Views
10 Pages

Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience

  • Rami Nassabein,
  • Laura Mansour,
  • Corentin Richard,
  • Franck Vandenbroucke-Menu and ,
  • Francine Aubin,
  • Jean-Pierre Ayoub,
  • Michel Dagenais,
  • Real Lapointe,
  • Richard Letourneau and
  • Mustapha Tehfe
  • + 8 authors+ 3 authors

18 May 2021

Surgery is the only potential curative option of CRLM if resectable. The curative approach in patients over 70 years old is challenging mainly because of comorbidities and other geriatric syndromes. Herein, we report outcomes of older patients with r...

  • Article
  • Open Access
4 Citations
2,690 Views
7 Pages

DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population

  • Maria Samara,
  • Maria Papathanassiou,
  • Lampros Mitrakas,
  • George Koukoulis and ,
  • Panagiotis J. Vlachostergios and
  • Vassilios Tzortzis
  • + 1 author+ 0 author

14 May 2021

Single nucleotide polymorphisms (SNPs) in DNA repair genes may predispose to urothelial carcinoma of the bladder (UCB). This study focused on three specific SNPs in a population with high exposure to environmental carcinogens including tobacco and al...

(This article belongs to the Special Issue Current Advances in Clinical Genomics and Treatment of Urothelial Carcinoma)
  • Article
  • Open Access
14 Citations
3,962 Views
13 Pages

Clinicopathological Risk Factors for Contralateral Lymph Node Metastases in Intraoral Squamous Cell Carcinoma: A Study of 331 Cases

  • Christian Flörke,
  • Aydin Gülses,
  • Christina-Randi Altmann,
  • Jörg Wiltfang and ,
  • Henning Wieker and
  • Hendrik Naujokat
  • + 1 author+ 0 author

14 May 2021

The current study aimed to examine the effects of clinicopathological factors, including the region, midline involvement, T classification, histological grade, and differentiation of the tumor on the rate of contralateral lymph node metastasis for or...

  • Article
  • Open Access
17 Citations
5,572 Views
12 Pages

Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis

  • Brane Grambozov,
  • Evelyn Nussdorfer,
  • Julia Kaiser,
  • Sabine Gerum and ,
  • Gerd Fastner,
  • Markus Stana,
  • Christoph Gaisberger,
  • Romana Wass,
  • Michael Studnicka and
  • Franz Zehentmayr
  • + 6 authors+ 1 author

13 May 2021

The treatment of locally recurrent lung cancer is a major challenge for radiation-oncologists, especially with data on high-dose reirradiation being limited to small retrospective studies. The aim of the present study is to assess overall survival (O...

(This article belongs to the Section Thoracic Oncology)
  • Article
  • Open Access
6 Citations
4,989 Views
10 Pages

Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer

  • Megan M. Tu,
  • Mark Clemons,
  • Carol Stober,
  • Ahwon Jeong and ,
  • Lisa Vandermeer,
  • Mihaela Mates,
  • Phillip Blanchette,
  • Anil Abraham Joy,
  • Olexiy Aseyev and
  • Kednapa Thavorn
  • + 8 authors+ 3 authors

13 May 2021

A cost–utility analysis was performed based on the Rethinking Clinical Trials (REaCT) bone-targeted agents (BTA) clinical trial that compared 12-weekly (once every 12 weeks) (n = 130) versus 4-weekly (once every 4 weeks) (n = 133) BTA dosing for meta...

  • Article
  • Open Access
11 Citations
3,842 Views
10 Pages

13 May 2021

Background: Recent clinical trial results reported that stereotactic radiotherapy (SABR) may improve survival for patients with oligometastatic (OM) cancer. Given that these results come from a phase II trial, there remains considerable uncertainty a...

  • Article
  • Open Access
39 Citations
6,046 Views
12 Pages

Psychosocial Distress in Adult Patients Awaiting Cancer Surgery during the COVID-19 Pandemic

  • David Forner,
  • Sarah Murnaghan,
  • Geoffrey Porter,
  • Ross J. Mason and ,
  • Paul Hong,
  • S. Mark Taylor,
  • James Bentley,
  • Gregory Hirsch,
  • Christopher W. Noel and
  • Robin Urquhart
  • + 11 authors+ 6 authors

13 May 2021

Cancer causes substantial emotional and psychosocial distress, which may be exacerbated by delays in treatment. The COVID-19 pandemic has resulted in increased wait times for many patients with cancer. In this study, the psychosocial distress associa...

  • Article
  • Open Access
7 Citations
3,378 Views
12 Pages

12 May 2021

Purpose: To evaluate the diagnostic performance of PI-RADS v2, proposed adjustments to PI-RADS v2 (PA PI-RADS v2) and biparametric magnetic resonance imaging (MRI) for prostate cancer detection. Methods: A retrospective cohort of 224 patients with su...

  • Article
  • Open Access
5 Citations
2,711 Views
8 Pages

11 May 2021

Despite the increasing application of transanal endoscopic microsurgery (TEM) for rectal lesions, the cost of the equipment may play a role in a hospital’s hesitancy to invest in the platform. This study compares the cost of TEM to laparoscopic low a...

(This article belongs to the Section Health Economics)
  • Review
  • Open Access
53 Citations
9,056 Views
20 Pages

Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer

  • Samitha Andrahennadi,
  • Amer Sami,
  • Mita Manna,
  • Mehrnoosh Pauls and
  • Shahid Ahmed

11 May 2021

Background: Hormone receptor-positive and HER2-negative breast cancer (HR + BC) is the most prevalent breast cancer. Endocrine therapy is the mainstay of treatment, however, due to the heterogeneous nature of the disease, resistance to endocrine ther...

  • Brief Report
  • Open Access
1 Citations
3,041 Views
5 Pages

10 May 2021

Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm that is genetically characterized by the absence of both the Philadelphia chromosome and BCR-ABL1 fusion gene and the high prevalence of mutations in the colony-stimulating fac...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
15 Citations
3,776 Views
10 Pages

Impact of an Augmented Reality Navigation System (SIRIO) on Bone Percutaneous Procedures: A Comparative Analysis with Standard CT-Guided Technique

  • Eliodoro Faiella,
  • Gennaro Castiello,
  • Caterina Bernetti,
  • Giuseppina Pacella and ,
  • Carlo Altomare,
  • Flavio Andresciani,
  • Bruno Beomonte Zobel and
  • Rosario Francesco Grasso
  • + 3 authors+ 0 author

8 May 2021

(1) Background: The purpose of this study is to evaluate the impact of an augmented reality navigation system (SIRIO) for percutaneous biopsies and ablative treatments on bone lesions, compared to a standard CT-guided technique. (2) Methods: Bioptic...

(This article belongs to the Special Issue Treatment of Bone Metastasis)
  • Article
  • Open Access
8 Citations
3,888 Views
12 Pages

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)

  • Elisa Giommoni,
  • Evaristo Maiello,
  • Vanja Vaccaro,
  • Ermanno Rondini and ,
  • Caterina Vivaldi,
  • Giampaolo Tortora,
  • Laura Toppo,
  • Guido Giordano,
  • Tiziana Pia Latiano and
  • Francesco Di Costanzo
  • + 9 authors+ 4 authors

8 May 2021

Background: Relevant improvement in first-line treatment of metastatic pancreatic cancer (mPC) was provided by FOLFIRINOX and by gemcitabine (gem) plus nab-paclitaxel (Nab-p) regimens. Regardless of the first-line treatment survival benefit, most pat...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
10 Citations
4,088 Views
17 Pages

Predictors of Urgent Cancer Care Clinic and Emergency Department Visits for Individuals Diagnosed with Cancer

  • Kathleen Decker,
  • Pascal Lambert,
  • Katie Galloway,
  • Oliver Bucher and ,
  • Marshall Pitz,
  • Benjamin Goldenberg,
  • Harminder Singh,
  • Mark Kristjanson,
  • Tunji Fatoye and
  • Eric J. Bow
  • + 5 authors+ 0 author

8 May 2021

In 2013, CancerCare Manitoba (CCMB) launched an urgent cancer care clinic (UCC) to meet the needs of individuals diagnosed with cancer experiencing acute complications of cancer or its treatment. This retrospective cohort study compared the character...

  • Case Report
  • Open Access
3 Citations
3,520 Views
7 Pages

Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma

  • Laura Burgess,
  • Marissa Keenan,
  • Alan Liang Zhou,
  • Kiefer Lypka and ,
  • Delvina Hasimja Saraqini,
  • Jeff Yao,
  • Samuel Martin,
  • Christopher Morash,
  • James Watterson and
  • Robert MacRae
  • + 6 authors+ 1 author

7 May 2021

Approximately 20% of renal cell carcinoma (RCC) is diagnosed because of paraneoplastic manifestations. RCC has been associated with a large variety of paraneoplastic syndromes (PNS), but it is rarely associated with PNS vasculitis. We present a case...

of 2

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729